Providence, RI - In a new study, even mild degrees of preoperative anemia or polycythemia (high red blood cell count) were associated with an increased risk of 30-day postoperative mortality and ...

Please provide your email address to receive an email when new articles are posted on . High hematocrit levels were observed among 8.4% of adults receiving gender-confirming testosterone therapy.

The decision as to when to give blood transfusions is complex, requiring a careful assessment of risks and benefits. The TRACS trial compared the effects of giving ...

SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years and significantly reduced use of phlebotomy, a small randomized trial showed. The ...

Older patients with mild degrees of pre-operative anemia (low red blood cell count) or those with a very high red blood cell count have a higher risk of post-operative death or cardiac events ...

Credit: Thinkstock. The risk of hematocrit elevation may depend on testosterone therapy's route of administration, according to investigators. A rise in hematocrit levels occurs with 4 months of ...

Background: Randomized trials found that use of erythropoiesis-stimulating agents to target normal hematocrit (Hct) levels (> 39%) compared with 27%–34.5% increases ...

Researchers explored the incidence of erythrocytosis in the first 20 months of testosterone therapy among people receiving gender-affirming hormone therapy (GAHT). Specifically, they conducted a ...

Please provide your email address to receive an email when new articles are posted on . Induction therapy with twice-weekly rusfertide helped patients with polycythemia vera achieve target hematocrit ...